Autoimmunity Reviews

Article	Citations
Editorial Board	236
The rationale for the use of corticosteroids in early severe Guillain-Barré syndrome	174
Editorial Board	149
“Fibromyalgia syndrome” related to Essure devices	136
Leflunomide: A safe and effective alternative in systemic lupus erythematosus	134
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review	98
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	90
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	86
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders	86
Editorial Board	85
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases	84
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	80
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	74
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management	69
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	67
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	67
Susac syndrome: A scoping review	66
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes	61
Endometriosis and autoimmunity	61
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology	61
Editorial Board	61
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature	59
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction	59
Can anticoagulation be withdrawn in APS patients after aPL negativization?	57
Psychiatric manifestations of autoimmune encephalitis	56

Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	56
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate	55
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy	54
The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned	54
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021	52
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	51
Inflammatory bowel disease in primary immunodeficiency disorders is a heterogeneous clinical entity requiring an individualized treatment strategy: A systematic review	50
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination	49
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered	48
Seronegative autoimmune diseases: A challenging diagnosis	47
Autoimmunity in vitiligo: Therapeutic implications and opportunities	45
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	44
Autoimmune pre-disease	43
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases	42
Cardiovascular outcome in adult-onset Kawasaki disease	41
A descriptive study of IgG4-related disease in children and young adults	41
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis	41
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database	40
Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence	40
Editorial Board	40
Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases	40
Refining search and keyword strategies in autoimmune ear disease bibliometric studies	40
Adipose failure through adipocyte overload and autoimmunity	39
Cerebral vasculitis as a clinical manifestation of neurosarcoidosis: A scoping review	39
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica	38
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases	36
IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies	36
Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases	36
SpA plus IBD or IBD plus SpA: Does commutative property apply?	36
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium	35
Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy	35
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges	35
Histopathological features of systemic sclerosis-associated myopathy: A scoping review	35
Editorial Board	34
Are breast cancer patients diagnosed after systemic sclerosis showing different pathological characteristics?	34
Complex relationships of type 2 and type 1 symptoms across various systemic autoimmune diseases.	33
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?	33
The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases	33
Zipper method is the emerging treatment option for severe Guillain-Barre syndrome related COVID-19	33
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort	33
Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies	32
Fibromyalgia: Are we using the biopsychosocial model?	32
Tumor necrosis factor-α inhibitor-related autoimmune disorders	31
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis	30
The myristoylated alanine-rich C-kinase substrates (MARCKS): A membrane-anchored mediator of the cell function	30
Development of an algorithm for IgG4-related disease management	30
Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines	30
The role of mitochondrial dysfunction in kidney injury and disease	28
Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review	28
Reply letter to letter to the editor	27

Dysfunction of the glymphatic system and sleep disturbance in rheumatoid arthritis and musculoskeletal pain: A gap related to pain becoming chronic	27
Are IF-ANA the guiding light for SLE classification in the real-world setting?	27
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease	27
Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis	26
Twenty shades of the mosaic of autoimmunity	26
Anti-rods/rings autoantibodies in a patient with pancreatic injury	26
Will a hyperactive classical complement pathway exacerbate autoimmune diseases?	26
Editorial Board	26
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechan	25
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies	25
Editorial Board	25
Tumors, tumor therapies, autoimmunity and the eye	24
Global burden due to modifiable risk factors for autoimmune diseases, 1990–2021: Temporal trends and socio-demographic inequalities	24
Mucous membrane pemphigoid	24
In Memoriam: Pierre Youinou	24
Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the two	24
Editorial Board	24
Alarmins in autoimmune diseases	24
Rheumatological complications of Covid 19	24
From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice	23
Reactive oxygen species: The Yin and Yang in (auto-)immunity	23
Editorial Board	23
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions	23
Neuroimaging in thyroid eye disease: A systematic review	23
Cutting edge confusion about cut-off settings in autoimmune diagnostics	23
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	22
Emerging role of Tissue Resident Memory T cells in vitiligo: From pathogenesis to therapeutics	22
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023	22
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study	22
Mucosal immunity and rheumatoid arthritis: An update on mechanisms and therapeutic potential	22
Editorial Board	21
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms	21
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue	21
Genetic and genomic associations in antiphospholipid syndrome: A systematic review	20
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers	20
Inflammatory muscle involvement in systemic vasculitis: A systematic review	20
Salivary gland involvement in ANCA-associated vasculitis	20
Is it time for treat-to-target in antiphospholipid syndrome?	20
Diagnostic approach in giant cell arteritis	20
Persistent aortic inflammation in patients with giant cell arteritis	20
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data	20
Epidemiology of major relapse in giant cell arteritis: A study-level meta-analysis	20
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target	20
Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis	20
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians	20
JAK inhibitors and systemic sclerosis: A systematic review of the literature	20
Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system	20
Serum calprotectin is a marker of disease activity in Giant cell arteritis	20
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals	19
Editorial Board	19
From inflammation to renal fibrosis: A one-way road in autoimmunity?	19
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019	19
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis	19
Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: A systematic review and met	18
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology	18
Don't mix apples and oranges. Reply to Azoulay et al.	18
Drug-induced antiphospholipid syndrome: Analysis of the WHO international database	18
Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: A systematic review and meta-analysis	18
Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care	18
COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity?	18
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation	17
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications	17
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases	17
Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent	17
Therapeutic potential of chimeric antigen receptor based therapies in autoimmune diseases	17
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction	16
The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity	16
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease	16
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports	16
Autoimmunity and COVID-19 – The microbiotal connection	16
CCR6-CCL20 axis as a therapeutic target for autoimmune diseases	16
Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases?	16
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis	16
Research advances on targeted-Treg therapies on immune-mediated kidney diseases	16
Intermittent fasting: A promising dietary intervention for autoimmune diseases	16
Scleroderma specific autoantibodies and MS-like manifestations: A novel association?	16
Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies)	16
Prevention of rheumatoid arthritis using a familial predictive medicine approach	15
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management	15
Janus kinase inhibitors for psoriatic arthritis: Evidence from a systematic review and network meta-analysis	15

Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions	15
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series	15
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)	15
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis	15
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review	15
Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel	15
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review	15
Covid vaccination in patients with autoimmune diseases treated with mycophenolate: Let's think back to the recommendations	14
Letter to the editor regarding a meta-analysis of JAK inhibitors and psoriatic arthritis	14
Editorial Board	14
Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy and COVID19 vaccination: Correspondence	14
Multiple sclerosis and pregnancy: Pathogenesis, influencing factors, and treatment options	14
Insights into new-onset autoimmune diseases after COVID-19 vaccination	14
Involvement of aquaporin 5 in Sjögren’s syndrome	14
Takotsubo syndrome occurring in systemic diseases: A French multicenter retrospective case-control study and literature review	14
Early skeletal muscle manifestations in polyarteritis nodosa and ANCA-associated vasculitis	14
Prenatal and perinatal factors associated with developing multiple sclerosis later in life: A systematic review and meta-analysis	14
Anti-glomerular basement membrane vasculitis	14
Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus	14
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain	14
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis	14
Editorial Board	14
Global research landscape on antiphospholipid syndrome and systemic lupus erythematosus: Trends, collaborations, and future directions	13
The relationship between BAFF serum levels, anti-NMDAR autoantibodies and fatigue in patients with systemic lupus erythematosus and multiple sclerosis	13
From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies	13
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Iss	13
Does a window of opportunity for rheumatoid arthritis-associated interstitial lung disease exist?	13
Outcomes of ICU patients treated with intravenous immunoglobulin for sepsis or autoimmune diseases	13
Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation	13
Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies	13
Relapses in giant cell arteritis: Updated review for clinical practice	13
Effect of exercise training on fatigue and pain in patients with systemic autoimmune myopathies: A systematic review	13
Editorial Board	13
Macrophage metabolic reprogramming: A trigger for cardiac damage in autoimmune diseases	12
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and exper	12
Gut microbiota–microRNA interactions in ankylosing spondylitis	12
Editorial Board	12
Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?	12
Intravenous immunoglobulin as a therapy for autoimmune conditions	12
The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis	12
Letter to the editor: Keratitis fugax hereditaria is an eye-specific cryopyrin-associated periodic syndrome	11
Comprehensive analysis of cell lineages involved in giant cell arteritis pathogenesis using highly multiplexed imaging mass cytometry	11
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus	11
Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: Data from 1990 to 2019	11
Exposome: Epigenetics and autoimmune diseases	11
A new challenge for lupus nephritis management: Induction therapy without immunosuppressive maintenance regimen	11
Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets	11
Short-term and low-dose IL-2 therapy increases the reduced Treg cells in patients with microscopic polyangiitis	11
Single centre experience of 120 patients with non-infectious aortitis: Clinical features, treatment and complications	11
Paraneoplastic autoimmune Laminin-332 syndrome (PALS): Anti-Laminin-332 mucous membrane pemphigoid as a prototype	11
Editorial Board	11
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort	11
Crossreactivity: The possible role of oral microbiota in oral mucous membrane pemphigoid	11
Circadian clock genes as promising therapeutic targets for autoimmune diseases	11
B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis	11
Efficacy, safety, and tolerability of antifibrotic agents in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	10
ChatGPT and autoimmunity – A new weapon in the battlefield of knowledge	10
COVID-19, G protein-coupled receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis	10
Aquaporins: Unexpected actors in autoimmune diseases	10
Disease modifying therapies in relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis	10
ANCA and anti-glomerular basement membrane double-positive patients: A systematic review of the literature	10
Residual pain in rheumatoid arthritis: Is it a real problem?	10
Risk of venous thromboembolism in autoimmune diseases: A comprehensive review	10
Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?	10
Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides	10
Building a monitoring matrix for the management of multiple sclerosis	10
Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: A systematic review	10
Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases	10
Effects of nutritional supplements and dietary interventions on rheumatoid arthritis: An umbrella review of meta-analyses of randomized controlled trials	9
Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus	9
Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force	9
Association between breastfeeding and the risk of autoimmune diseases: A systematic review and meta-analysis	9
Unraveling the global burden of inflammatory bowel disease (1990–2019): A Joinpoint regression analysis of divergent trends in 10–24 and 50–69 age cohorts	9
Immunometabolic shifts in autoimmune disease: Mechanisms and pathophysiological implications	9
IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19	9
SLE patients with childhood-onset: A nation-wide population-based study	9
Key points to consider for an improved detection and characterization of cryoglobulins	9
Autoreactive T cells of ankylosing spondylitis elicited by COVID-19 infection: A snapshot of immunological host defense and autoimmune imprinting	9
Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019	9
Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues	9
Diagnostic yield of combined cranial and large vessel PET/CT, ultrasound and MRI in giant cell arteritis: A systematic review and meta-analysis	9
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience	9
Current state of epigenetics in giant cell arteritis: Focus on microRNA dysregulation	9
Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases	9
Renal involvement in systemic sclerosis	9
Editorial Board	9
Letter to the editor: Prevalence of connective tissue disease autoantibodies in a large longitudinal population-based cohort from the Netherlands	8
Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?	8
Assessment and management for latent tuberculosis before advanced therapies for immune-mediated inflammatory diseases: A comprehensive review	8
Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal	8
Renal autoimmunity: The role of bacterial and viral infections, an extensive review	8
Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic	8
Lung involvement in juvenile idiopathic inflammatory myopathy: A systematic review	8
Longitudinal monitoring of circulating immune cell phenotypes in anti-neutrophil cytoplasmic antibody-associated vasculitis	8
A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis	8